Novo Nordisk
NVO
#21
Rank
$461.38 B
Marketcap
$101.64
Share price
-3.49%
Change (1 day)
2.46%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Novo Nordisk (NVO) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : $41.48 Billion USD

According to Novo Nordisk's latest financial reports the company's total liabilities are $41.48 Billion USD. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Novo Nordisk - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31$30.79 B35.54%
2022-12-31$22.72 B20.58%
2021-12-31$18.84 B39.7%
2020-12-31$13.48 B32.26%
2019-12-31$10.19 B12.95%
2018-12-31$9.02 B6.6%
2017-12-31$8.47 B14.45%
2016-12-31$7.40 B12.65%
2015-12-31$6.56 B9.4%
2014-12-31$6.00 B16.81%
2013-12-31$5.14 B15.8%
2012-12-31$4.43 B-6.48%
2011-12-31$4.74 B8.85%
2010-12-31$4.36 B19.1%
2009-12-31$3.66 B10.36%
2008-12-31$3.31 B8.87%
2007-12-31$3.04 B17.98%
2006-12-31$2.58 B14.05%
2005-12-31$2.26 B13.01%
2004-12-31$2.00 B28.87%
2003-12-31$1.55 B26.39%
2002-12-31$1.23 B-2.17%
2001-12-31$1.25 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
$126.91 B 205.95%๐Ÿ‡บ๐Ÿ‡ธ USA
$61.28 B 47.74%๐Ÿ‡บ๐Ÿ‡ธ USA
$76.47 B 84.34%๐Ÿ‡บ๐Ÿ‡ธ USA
$60.84 B 46.67%๐Ÿ‡ซ๐Ÿ‡ท France